To hear about similar clinical trials, please enter your email below
Trial Title:
Assessing Frailty and Its Impacts on Patients Facing Major GI Surgery
NCT ID:
NCT06267378
Condition:
Bowel Cancer
Conditions: Official terms:
Frailty
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Frailty measure
Description:
All participants will be asked to complete baseline assessments and a blood test.
30 participants out of the 100 will be selected to wear a digital motion device before
their surgery for seven days. (15 participants will be non-frail and 15 patients will be
frail).
Where possible, all baseline assessments will be scheduled to coincide with a routine
clinic/hospital visit. The first assessment will complete functional, frailty,
nutritional, and quality of life questionnaires. A blood test will be taken for baseline
tests and metabolomic assessment. Participants who opt into having a digital motion
device will also be shown how to use the device and will wear this for seven days.
Written instructions to fit the device will also be given.
Summary:
The study team will look at 3 new tests that will make it easier to measure frailty in
patients awaiting surgery for cancer and compare them against standard clinical measures
of frailty in a pilot study. The expected outcome is that evidence will be collated in
order to apply for a major grant to look at improving the care of frail patients with
cancer in the future.
Detailed description:
Over 40% of patients with bowel cancer are over the age of 75. In older patients, rates
of ill health and frailty are high, with frailty found in 6 in 10 patients over the age
of 90. Surgery is the main treatment for bowel cancer, but the risks of surgery are
higher in older people especially if they are frail. The main features of frailty are
weight loss, lack of energy, weakness, slow walking speed and low activity levels.
Frailty is a condition linked to an increased risk of death and major complications after
surgery. As a result, older and frailer patients are often refused surgery for their
cancer. If we could identify frailty more reliably before surgery, we could offer
patients better counselling about the surgical risks and benefits. We could also offer
treatments that might improve their fitness, making the surgery safer (pre-operative
exercise, better post-operative support). Surgeons are not very good at measuring frailty
because the clinical tests for it are complicated and take a long time to complete.
Criteria for eligibility:
Study pop:
Gastrointestinal cancer patients
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
1. Male or female.
2. Aged 70 years and over.
3. Patients with a diagnosis of primary operable colorectal cancer where treatment
includes a planned curative surgical procedure.
4. About to undergo elective surgery for cancer.
5. Mental capacity to consent.
Exclusion Criteria:
1. Patients with unresectable cancer.
2. Patients presenting as an emergency.
3. Patients who are having chemotherapy or radiotherapy before their surgery.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
Address:
City:
Doncaster
Zip:
DN2 5LT
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
Doncaster Royal Infirmary
Email:
dbth.clinicalresearch@nhs.net
Start date:
August 30, 2023
Completion date:
December 1, 2029
Lead sponsor:
Agency:
Doncaster And Bassetlaw Hospitals NHS Foundation Trust
Agency class:
Other
Source:
Doncaster And Bassetlaw Hospitals NHS Foundation Trust
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06267378